These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2471825)

  • 61. Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors.
    Zukin SR; Brady KT; Slifer BL; Balster RL
    Brain Res; 1984 Feb; 294(1):174-7. PubMed ID: 6199090
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interaction of the discriminative stimulus effects of phencyclidine with those of (+)-N-allylnormetazocine, pentobarbital and d-amphetamine.
    McMillan DE; Wessinger WD
    Pharmacol Biochem Behav; 1989 Mar; 32(3):711-5. PubMed ID: 2740424
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interaction of sigma and PCP-like drugs on operant behaviors in the rat.
    Hudzik TJ; Slifer BL
    Psychopharmacology (Berl); 1992; 108(1-2):115-22. PubMed ID: 1410131
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Evaluation of the discriminative stimulus effect of an enkephalin analog, EK-399, in the rat].
    Nishida N; Yasuhara Y; Chiba S
    Nihon Yakurigaku Zasshi; 1991 Jun; 97(6):361-9. PubMed ID: 1651892
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Discriminative stimulus effects of prototype opiate receptor agonists in monkeys.
    Teal JJ; Holtzman SG
    Eur J Pharmacol; 1980 Nov; 68(1):1-10. PubMed ID: 6256182
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Three-choice drug discrimination: phencyclidine-like stimulus effects of opioids.
    White JM; Holtzman SG
    Psychopharmacology (Berl); 1983; 80(1):1-9. PubMed ID: 6408661
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Discriminative stimulus properties of narcotic and non-narcotic drugs in rats trained to discriminate opiate kappa-receptor agonists.
    Shearman GT; Herz A
    Psychopharmacology (Berl); 1982; 78(1):63-6. PubMed ID: 6292982
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Biochemical, behavioral, and electrophysiologic actions of the selective sigma receptor ligand (+)-pentazocine.
    Steinfels GF; Alberici GP; Tam SW; Cook L
    Neuropsychopharmacology; 1988 Dec; 1(4):321-7. PubMed ID: 2855202
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oral self-administration of N-allylnormetazocine (SKF-10,047) stereoisomers in rhesus monkeys: substitution during phencyclidine self-administration and withdrawal.
    Carroll ME
    Pharmacol Biochem Behav; 1988 Jun; 30(2):493-500. PubMed ID: 3174781
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Receptor mediation of the discriminative stimulus properties of phencyclidine and sigma-opioid agonists.
    Balster RL; Willetts J
    Psychopharmacol Ser; 1988; 4():122-35. PubMed ID: 2899317
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of phencyclidine (PCP)-like drugs on turning behavior, 3H-dopamine uptake, and 3H-PCP binding.
    Johnson KM; Snell LD
    Pharmacol Biochem Behav; 1985 May; 22(5):731-5. PubMed ID: 2989942
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [3H]PCP-3-OH and (+)[3H]SKF 10047 binding sites in rat brain membranes: evidence of multiplicity.
    Itzhak Y
    Eur J Pharmacol; 1987 Apr; 136(2):231-4. PubMed ID: 3036548
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity.
    Freeman AS; Bunney BS
    Eur J Pharmacol; 1984 Sep; 104(3-4):287-93. PubMed ID: 6094217
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Phencyclidine-induced inhibition of striatal acetylcholine release: comparisons with mu, kappa, and sigma opiate agonists.
    Leventer SM; Johnson KM
    Life Sci; 1984 Feb; 34(8):793-801. PubMed ID: 6366418
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antagonism of the discriminative stimulus effects of the kappa-opioid agonist spiradoline.
    Holtzman SG; Steinfels GF
    Psychopharmacology (Berl); 1994 Nov; 116(3):243-8. PubMed ID: 7892412
    [TBL] [Abstract][Full Text] [Related]  

  • 76. N-allylnormetazocine (SKF-10,047): the induction of feeding by a putative sigma agonist.
    Gosnell BA; Levine AS; Morley JE
    Pharmacol Biochem Behav; 1983 Nov; 19(5):737-42. PubMed ID: 6316372
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Psychotomimetic sigma-ligands, dexoxadrol and phencyclidine block the same presynaptic potassium channel in rat brain.
    Bartschat DK; Blaustein MP
    J Physiol; 1988 Sep; 403():341-53. PubMed ID: 3253423
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cardiovascular and respiratory effects of an opioid kappa agonist ethylketazocine and sigma agonist N-allylnormetazocine in acutely decerebrated dogs.
    Wu KM; Martin WR
    Pharmacol Biochem Behav; 1989 Oct; 34(2):405-11. PubMed ID: 2695944
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evidence for multiple opiate receptor involvement in different phencyclidine-induced unconditioned behaviors in rats.
    Greenberg BD; Segal DS
    Psychopharmacology (Berl); 1986; 88(1):44-53. PubMed ID: 3003779
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of repeated haloperidol administration on phencyclidine discrimination in rats.
    Wiley JL
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jul; 19(4):699-711. PubMed ID: 8588067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.